How do you manage a patient with Ogilvie's syndrome presenting with a cecal diameter above 12 cm unresponsive to conservative management with electrolyte correction, decompression by flexible sigmoidoscopy, and rectal tube placement?

While neostigmine has traditionally been used in this setting, it often faces pushback from both the hospital and pharmacy due to the need for cardiac monitoring. Additionally, it's not suitable for long-term use. Instead, I’ve been using pyridostigmine, which does not require cardiac monitoring and...